Related Experiment Video

Updated: May 21, 2026

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
15:04

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

Immune modulation by molecular cancer targets and targeted therapies: Rationale for novel combination strategies

Claudia Rossig1

  • 1Department of Pediatric Hematology and Oncology; University Children's Hospital Muenster; Muenster, Germany.

Oncoimmunology
|June 28, 2012
PubMed

Insights

Natural Killer (NK) cell alterations in BCR-ABL myeloproliferation persist despite targeted therapy. This suggests oncogenic pathways interfere with immune function, necessitating combined treatment strategies for better cancer targeting.

Area of Science:

  • Immunology
  • Oncology
  • Pharmacology

Background:

  • Alterations in Natural Killer (NK) cell populations are observed in BCR-ABL-induced myeloproliferation.
  • These NK cell compartment changes do not revert even with targeted therapy.

Purpose of the Study:

  • To explore the mechanisms by which oncogenic molecular pathways and their inhibition impact immune functions.
  • To discuss the potential of combining molecularly targeted and immunological strategies for enhanced cancer treatment.

Main Methods:

  • Review of existing observations on NK cell behavior in BCR-ABL myeloproliferation.
  • Discussion of molecular pathways involved in oncogenesis and targeted therapy.
  • Analysis of potential interactions between pharmacological inhibition and immune system functions.

Main Results:

  • Oncogenic molecular pathways and their pharmacological inhibition can interfere with immune functions, specifically NK cell activity.
  • The persistence of NK cell alterations suggests a complex interplay between cancer biology and immune response.

Conclusions:

  • Understanding the interference of oncogenic pathways with immune functions is crucial.
  • Rational combinations of targeted therapy and immunotherapy may offer a more effective approach to cancer treatment.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...